To include your compound in the COVID-19 Resource Center, submit it here.

Mission: Mainstream

How Mission Bio plans to expand Tapestri’s reach with a $30M series B

Mission Bio Inc. plans to deploy its $30 million series B round to expand the applications and client base for its single-cell DNA analysis platform.

Agilent Technologies Inc. (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM Research Capital and

Read the full 401 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE